Thymosin alpha-1 / LL-37 stack: what's in it

The short answer

Thymosin alpha-1 / LL-37 stack combines Thymosin alpha-1 and LL-37.

  • What it is

    Immune stack.

  • What people look into

    Skin and hair, aging

    Results for one compound don't tell you what the two do together.

The parts

Regulatory status by component

Not FDA-approved How we label status

Status as of October 4, 2026

As a combination
No category as a combination (see components)
  • Thymosin alpha-1: as of October 4, 2026 · source
  • LL-37 (cathelicidin): as of October 4, 2026 · source

Get updates on Thymosin alpha-1 / LL-37 stack

We'll store your email, your state, the page you're on and the peptides selected below (pre-selected from this page; untick any). Together these can reveal health interests. We use them only for what you tick below and to count sign-ups by state and peptide, without emails, to plan where the clinic opens and for reports that show only totals. Our hosting, database and email providers handle them for us. We pass them to a doctor or clinic only if you tick that box, and we don't sell them. Withdraw anytime with the unsubscribe link or at hello@ellumclinic.com. Consumer Health Data Privacy Policy

Ellum's sign-ups are for adults 18 and over.

Peptides: Thymosin alpha-1 / LL-37 stack (1 selected) · edit
Peptides you're interested in
What we may email you about
More options (optional): research, doctor contact, paid offers

The research on Thymosin alpha-1 / LL-37 stack

Key facts

Also known as: ta1 ll-37, immune resilience stack

Parts
Thymosin alpha-1 and LL-37 (cathelicidin)
Route
injectable

References

Status sources

Sources as of October 4, 2026

  1. FDA: api.fda.gov/drug/drugsfda.json
  2. FDA: www.fda.gov/media/94155/download

What this doesn’t establish

Results for one compound don't tell you what the two do together.